MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.

Journal: Brain imaging and behavior
Published Date:

Abstract

Neuroanatomical pattern classification using support vector machines (SVMs) has shown promising results in classifying Multiple Sclerosis (MS) patients based on individual structural magnetic resonance images (MRI). To determine whether pattern classification using SVMs facilitates predicting conversion to clinically definite multiple sclerosis (CDMS) from clinically isolated syndrome (CIS). We used baseline MRI data from 364 patients with CIS, randomised to interferon beta-1b or placebo. Non-linear SVMs and 10-fold cross-validation were applied to predict converters/non-converters (175/189) at two years follow-up based on clinical and demographic data, lesion-specific quantitative geometric features and grey-matter-to-whole-brain volume ratios. We applied linear SVM analysis and leave-one-out cross-validation to subgroups of converters (n = 25) and non-converters (n = 44) based on cortical grey matter segmentations. Highest prediction accuracies of 70.4% (p = 8e-5) were reached with a combination of lesion-specific geometric (image-based) and demographic/clinical features. Cortical grey matter was informative for the placebo group (acc.: 64.6%, p = 0.002) but not for the interferon group. Classification based on demographic/clinical covariates only resulted in an accuracy of 56% (p = 0.05). Overall, lesion geometry was more informative in the interferon group, EDSS and sex were more important for the placebo cohort. Alongside standard demographic and clinical measures, both lesion geometry and grey matter based information can aid prediction of conversion to CDMS.

Authors

  • Kerstin Bendfeldt
    Medical Image Analysis Center (MIAC AG), Mittlere Str. 83, CH-4031, Basel, Switzerland. kerstin.bendfeldt@unibas.ch.
  • Bernd Taschler
    German Center for Neurodegenerative Diseases, Bonn, Germany.
  • Laura Gaetano
    Medical Image Analysis Center (MIAC AG), Mittlere Str. 83, CH-4031, Basel, Switzerland.
  • Philip Madoerin
    Medical Image Analysis Center (MIAC AG), Mittlere Str. 83, CH-4031, Basel, Switzerland.
  • Pascal Kuster
    Medical Image Analysis Center (MIAC AG), Mittlere Str. 83, CH-4031, Basel, Switzerland.
  • Nicole Mueller-Lenke
    Medical Image Analysis Center (MIAC AG), Mittlere Str. 83, CH-4031, Basel, Switzerland.
  • Michael Amann
    Medical Image Analysis Center (MIAC AG), Mittlere Str. 83, CH-4031, Basel, Switzerland.
  • Hugo Vrenken
    VU University Medical Center, Amsterdam, The Netherlands.
  • Viktor Wottschel
    Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands; Queen Square MS Centre, University College London, London, United Kingdom. Electronic address: v.wottschel@amsterdamumc.nl.
  • Frederik Barkhof
    MS Center Amsterdam, Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, the Netherlands.
  • Stefan Borgwardt
    Department of Psychiatry, University of Basel, Basel, Switzerland.
  • Stefan Klöppel
    Center of Geriatrics and Gerontology Freiburg, University Medical Center Freiburg, Freiburg, Germany.
  • Eva-Maria Wicklein
    Bayer Pharma AG, Berlin, Germany.
  • Ludwig Kappos
    Department of Neurology, University Hospital Basel, Basel, Switzerland.
  • Gilles Edan
    Univ Rennes, Inria, CNRS, Inserm, IRISA UMR, 6074, Visages U1128, France; CHU Rennes, Neurology Department, France.
  • Mark S Freedman
    University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Xavier Montalbán
    Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Hans-Peter Hartung
    Department of Neurology, Heinrich-Heine Universität, Düsseldorf, Germany.
  • Christoph Pohl
    Bayer Pharma AG, Berlin, Germany.
  • Rupert Sandbrink
    Bayer Pharma AG, Berlin, Germany.
  • Till Sprenger
    Medical Image Analysis Center (MIAC AG), Mittlere Str. 83, CH-4031, Basel, Switzerland.
  • Ernst-Wilhelm Radue
    Medical Image Analysis Center (MIAC AG), Mittlere Str. 83, CH-4031, Basel, Switzerland.
  • Jens Wuerfel
    Department Biomedical Engineering, Medical Image Analysis Center AG, University of Basel, Basel, Switzerland.
  • Thomas E Nichols
    Department of Statistics, University of Warwick, Coventry, UK.